Breaking News on Global Pharmaceutical Technology & Manufacturing


News headlines

Rise of the robots: UK pharma would gain from more automation investment says Barclays

01-Dec-2015 - UK drugmakers have a lot to gain from additional investment in robotic production technologies according to Barclays.

Pfizer-Allergan merger

‘Over 90%’ of industry thinks Pfizer will sell generics biz

30-Nov-2015 - Pfizer says it will decide in 2018 whether to split its generics and branded businesses but M&A experts are already predicting how the giant will get rid of its established drugs programme.

ManKind plans to build manufacturing plant in the Himalayas

30-Nov-2015 - ManKind Pharma plans to set up manufacturing facilities in Northeast India to bring production in-house and cut its tax bill.

Happy Thefts-giving: Drugmakers need to be extra vigilant during the holidays says expert

26-Nov-2015 - The number of pharmaceutical cargo thefts has fallen in recent years, but manufacturers still need to be vigilant according to an expert who says the holidays are a risky period.

FDA warning for Sandoz after data and training issues at Indian plants

25-Nov-2015 - Manipulated employee records and English-only training materials were among violations cited by the US FDA at two Indian plants, but Sandoz is confident these will be resolved.

Xellia buys ex-Ben Venue site and aims to restart production in 2017

25-Nov-2015 - Restarting production at the former Ben Venue facility in Ohio will be a “significant task” says Xellia Pharmaceuticals which plans to invest after buying the site from Hikma.

EC mulls changes to Orphan Drug rules

24-Nov-2015 - Tweaks to EU orphan drug rules (OD) may be needed to accommodate Ebola treatment development and block industry attempts to delay generic entry says the European Commission.

API sourcing leads US Gov to label Carlsbad's Acyclovir tablets as made in Asia

23-Nov-2015 - US Customs and Border Protection (CBP) says the country of origin of Carlsbad Technology’s acyclovir is where the API is sourced, not the US where the tablets are made.

Pharma unhappy with French 'made in EU' proposal

19-Nov-2015 - France's government has proposed new labelling for medicines that would indicate whether the contents were manufactured in or outside Europe.


CEO who ‘only employs beautiful women’ guilty of sex discrimination

18-Nov-2015 - The CEO of Immuno Biotech who said he only employs “beautiful women” and noted a candidate’s lipstick and high heels on her job application has been fined for sex discrimination.

Antibiotics: urgent calls for global payment pot

17-Nov-2015 - As World Antibiotics Awareness Week draws attention to the threat of resistance, pharma companies large and small say a worldwide overhaul of payment models will make anti-infective R&D profitable again.

Catalent: Suspension at French plant likely due to human interference

17-Nov-2015 - Out-of-place softgel capsules have led to the suspension of manufacturing at a site in France, and Catalent says the problem is almost certainly due to malicious actions.


MHRA medical assessors tackle challenging evolving drug complexity

12-Nov-2015 - The UK regulatory agency is recruiting for medical assessors, but with drug-device combinations, biologics and personalised medicines making the job more complex, do you have what it takes?

Recall round-up

Pfizer withdraws 20,000 Xanax, plus Hong Kong OTC recall

11-Nov-2015 - Pfizer has issued a recall of more than 20,000 bottles of Xanax after discovering the strength of the batch may be weaker than labelled.

AZ halts Dr Reddy’s ‘purple pill’ generic; firm responds to FDA Letter

11-Nov-2015 - In the second setback for Dr Reddy’s within a week, the District Court of Delaware has granted a temporary restraining order preventing the company from selling esomeprazole, the generic version of AstraZeneca’s Nexium.

Government blames India's poor quality stigma on 'turf war' with West

09-Nov-2015 - The over-reaction to quality infringements by Indian drugmakers is part of a “turf war” with Western firms, the Indian Government says.


Isys CEO resigns; job news at Merck and BI

09-Nov-2015 -

Three Dr Reddy’s sites hit with Warning Letters in India

09-Nov-2015 - Dr Reddy’s shares have slumped 14% after the company received an FDA Warning Letter over manufacturing conditions at three Indian sites.

Accelerated access

UK innovation drive will change licensing, reimbursement and trials

05-Nov-2015 - A UK government report on accelerated access to medicines proposes overhauling conditional licensing and reimbursement pathways to drive drug development.

Indiana aspirin maker hit with Warning due to tablet inconsistencies

04-Nov-2015 - Inconsistent tablet colour and issues with compressing procedures have landed Indiana OTC maker American Family Pharmacy (AFP) with a US FDA warning letter.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...

Product Innovation